Facial Plast Surg 2023; 39(01): 053-056
DOI: 10.1055/a-1967-6050
Original Article

The Management of Chemosis after Blepharoplasty

1   Department of Ophthalmology, University Hospital Antwerp, Edegem, Belgium
2   Faculty of Health Sciences, The University of Antwerp, Antwerp, Belgium
,
Callum Faris
2   Faculty of Health Sciences, The University of Antwerp, Antwerp, Belgium
3   Department of Otolaryngology, University Hospital Antwerp, Edegem, Belgium
4   The Face Institute, Amsterdam, The Netherlands
› Institutsangaben

Abstract

Chemosis is a common, though typically temporary complication of both upper and lower blepharoplasty surgery, though it is much more common after the latter. It occurs due to extravasation of fluid into the subconjunctival space precipitated by desiccation, inflammation, and manipulation of the conjunctiva and associated lymphatic drainage. Intraoperatively, minimizing surgical exposure and manipulation as well as maintaining a moist ocular surface can reduce the risks. Postoperatively, we propose a stepwise approach, starting with lubricants and escalating to increasingly potent anti-inflammatories with compression bandaging and surgery reserved for persistent cases.



Publikationsverlauf

Accepted Manuscript online:
25. Oktober 2022

Artikel online veröffentlicht:
15. Dezember 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Putterman AM. Treatment of conjunctival prolapse. Arch Ophthalmol 1995; 113 (05) 553-554
  • 2 Weinfeld AB, Burke R, Codner MA. The comprehensive management of chemosis following cosmetic lower blepharoplasty. Plast Reconstr Surg 2008; 122 (02) 579-586
  • 3 Nahai F, Wojno TH. Problems in Periorbital Surgery: A Repair Manual. New York: Thieme Publishers; 2019
  • 4 McCord CD, Kreymerman P, Nahai F, Walrath JD. Management of postblepharoplasty chemosis. Aesthet Surg J 2013; 33 (05) 654-661
  • 5 Enzer YR, Shorr N. Medical and surgical management of chemosis after blepharoplasty. Ophthal Plast Reconstr Surg 1994; 10 (01) 57-63
  • 6 Yokoi N, Komuro A, Nishii M. et al. Clinical impact of conjunctivochalasis on the ocular surface. Cornea 2005; 24 (8, Suppl): S24-S31
  • 7 Hosten LO, Snyder C. Over-the-counter ocular decongestants in the United States - mechanisms of action and clinical utility for management of ocular redness. Clin Optom (Auckl) 2020; 12: 95-105
  • 8 Raison-Peyron N, Du Thanh A, Demoly P, Guillot B. Long-lasting allergic contact blepharoconjunctivitis to phenylephrine eyedrops. Allergy 2009; 64 (04) 657-658
  • 9 Bagheri A, Javadi M, Shahraki K. Treatment of persistent chemosis after upper lid blepharoplasty by hand-held fine-tip cautery: report of a case. Middle East Afr J Ophthalmol 2019; 26 (02) 120-122
  • 10 Moesen I, Mombaerts I. Subconjunctival injection of tetracycline 2% for chronic bulbar chemosis after transcutaneous four-eyelid blepharoplasty. Ophthal Plast Reconstr Surg 2008; 24 (03) 219-220
  • 11 Cheng JH, Lu DW. Perilimbal needle manipulation of conjunctival chemosis after cosmetic lower eyelid blepharoplasty. Ophthal Plast Reconstr Surg 2007; 23 (02) 167-169